Verified assay purity, strict impurity limits, and complete lot traceability audited under certified cGMP frameworks.
Understanding the molecular properties and quality assurance indices of industrial pharmaceutical-grade Arecoline Hydrobromide powder.
Arecoline Hydrobromide (chemical formula: C₈H₁₃NO₂·HBr, CAS Registry Number: 300-08-3) is the hydrobromide salt of arecoline, a natural muscarinic acetylcholine receptor agonist traditionally isolated from the seeds of the betel palm (Areca catechu) or completely synthesized via precise chemical routes. As a crucial cholinergic agonist, it has long served as a vital tool in veterinary therapeutics (specifically as an anthelmintic and taeniacide), neurological receptor screening, and preclinical behavioral pharmacodynamics research.
In high-standard industrial synthesis and plant extraction refining, obtaining pharmaceutical intermediates with consistent assay purity (≥99.0% by HPLC) requires stringent crystal polymorphism management, rigorous residual hydrobromic acid control, and sub-ppm heavy metal stripping.
| Analytical Parameter | USP / EP Reference Standard Target | ShineHerb Factory Benchmark Spec | Methodology / Instrumentation |
|---|---|---|---|
| Appearance | White to almost white crystalline powder | Pure white crystal, odorless | Visual / Organoleptic Inspection |
| Assay Purity (dry basis) | 98.5% – 101.5% | ≥99.2% | High-Performance Liquid Chromatography (HPLC) |
| Melting Point Range | 169°C – 171°C | 170.0°C – 171.5°C (Decomposition) | Capillary Melting Method (USP <741>) |
| Solubility Profile | Freely soluble in water and ethanol | 100 mg/mL clear, colorless solution in H₂O | Turbidimetric Clarity Verification |
| Loss on Drying | ≤ 1.0% | ≤ 0.45% | Thermogravimetric Oven Drying (105°C) |
| Residue on Ignition | ≤ 0.1% | ≤ 0.05% | Muffle Furnace (800°C Ashing) |
| Heavy Metals (Pb, As, Cd, Hg) | ≤ 10 ppm total | ≤ 2 ppm (Individual < 0.5 ppm) | Inductively Coupled Plasma Mass Spectrometry (ICP-MS) |
Bridging pure synthesis science with scalable, real-world formulations across commercial therapeutic and experimental sectors.
Arecoline Hydrobromide remains an acknowledged parasiticide in veterinary pharmacopeias, notably for targeting cestodes (tapeworms) such as Echinococcus granulosus in canines and livestock. Our micro-milled crystalline morphology ensures homogenous dispersion in veterinary oral boluses and premixes, ensuring high bioavailability.
Acting as an unselective agonist across muscarinic acetylcholine receptor subtypes (M1, M2, M3, M4), it is critical for mapping cognitive deficits, Alzheimer's pathway signaling, and presynaptic memory impairment. Our ultra-purified salts guarantee absent secondary alkaloid interference, protecting research integrity.
Due to the tetrahydropyridine core scaffold, specialized pharmaceutical synthesis units use our high-purity arecoline salt as an essential precursor for structural derivatization, exploring next-generation muscarinic mimetics with decreased cardiotoxicity and heightened central nervous system targeting.
Transitioning from extractive extraction dependency toward continuous flow engineering and biocatalytic green synthesis.
Traditional batch bromination and N-methylation present high exotherm risks and color degradation. We are introducing micro-reaction continuous flow reactors that yield reaction residence times under 90 seconds, eliminating hotspot batch variations and ensuring uniform crystallization.
Collaborating with leading regional biochemistry laboratories in Shaanxi, our mid-term roadmap involves engineered microbial hosts for the asymmetric bio-production of nicotinic intermediate scaffolds, slashing organic solvent usage by over 60%.
Implementing supercritical CO₂ antisolvent recrystallization to replace excessive acetone/ethanol mother-liquor thermal steps. This drastically suppresses volatile organic compounds (VOCs) while delivering tailor-made crystal particle size distributions (D50, D90).
Harnessing state-of-the-art chemical engineering clusters in Shaanxi to ensure supply continuity and extreme cost-efficiency.
Our Xi'an high-tech manufacturing base leverages automated Distributed Control Systems (DCS) monitoring temperature, vacuum levels, dosing rates, and pH adjustments in real-time. This cuts human operational error down to zero across multi-ton annual outputs.
Direct supply line agreements with certified petrochemical basic synthesis feeds and regional agricultural extraction stations insulate buyers from volatile global price surges, offering 12-month fixed pricing and predictable delivery windows.
Equipped with computerized high-bay storage facilities, maintained under strictly monitored temperature (<25°C) and RH (<60%). Standard commercial quantities of 25kg, 50kg, and 500kg are maintained ready for customs clearing within 48 to 72 hours.
Comprehensive qualification data packs, reducing verification overhead for international QA auditors.
Every single batch is issued alongside an audited Certificate of Analysis (COA), 16-section GHS Safety Data Sheet (SDS/MSDS), Technical Specification Sheet (TDS), and clear synthetic route statements outlining absence of genotoxic impurities.
Our production protocols align strictly with ISO 9001 quality management, ISO 22000, HACCP, FDA registration benchmarks, and European REACH verification systems, ensuring smooth customs processing at North American and EU ports of entry.
Standard export configuration includes inner double polyethylene medical-grade liners within tamper-evident UN-approved fiber drums (1kg, 5kg, 25kg). Vacuum nitrogen flushing is implemented upon request to guarantee zero moisture absorption over ocean freight.
Key technical, commercial, and logistical clarifications for global buyers sourcing Arecoline Hydrobromide Powder.
Explore our wider catalog of pharmacopeial-grade raw materials engineered for leading health, nutrition, and pharmaceutical manufacturers.